Slab Contrasted Agja 2 is a regular weight, very wide, medium contrast, upright, tall x-height font.
Keywords: editorial, book text, headlines, branding, posters, classic, authoritative, scholarly, industrial, heritage, readability, authority, print texture, editorial voice, sturdiness, slab serifs, bracketed slabs, robust, high readability, text-oriented.
A robust slab-serif with pronounced, bracketed serifs and a steady, text-forward rhythm. Strokes show clear, controlled contrast: verticals read darker while horizontals and joins lighten slightly, keeping counters open and forms crisp. Proportions skew wide with ample set width and stable spacing, while the tall x-height and relatively short ascenders/descenders give lowercase lines a dense, efficient texture. Terminals and serifs are squared and confident, and the overall drawing favors sturdy geometry over calligraphic softness.
Well-suited to editorial design where a confident slab-serif voice is needed—magazine headings, section openers, pull quotes, and book or report titling. The tall x-height and strong serifs also make it a solid choice for packaging, institutional branding, and poster headlines that benefit from a grounded, traditional presence.
The tone is classic and authoritative, with a slightly industrial, editorial seriousness. It evokes traditional print typography—pragmatic and trustworthy—while the bolder slab presence adds emphasis and weight without feeling decorative.
Likely designed to deliver a durable, print-oriented slab-serif texture that balances readability with a bold, commanding silhouette. The combination of wide proportions, bracketed slabs, and measured contrast suggests an intent to bridge classic text traditions with an assertive editorial voice.
Uppercase forms feel stately and anchored by heavy slabs, and the numerals match the same sturdy, bookish character. In paragraph setting the face maintains a consistent color, with the wide proportions and tall x-height supporting clarity at larger text sizes and display-like editorial treatments.